Osteogenic differentiation of stem cells alters vitamin D receptor expression.
Pluripotent and multipotent stem cells adopt an osteoblastic phenotype when cultured in environments that enhance their osteogenic potential. Embryonic stem cells differentiated as embryoid bodies (EBs) in osteogenic medium containing β-glycerophosphate exhibit increased expression of bone markers, indicating that cells are osteoblastic. Interestingly, 1α,25-dihydroxyvitaminD3 (1,25D) enhances the osteogenic phenotype not just in EBs but also in multipotent adult mesenchymal stem cells (MSCs). 1,25D acts on osteoblasts via classical vitamin D receptors (VDR) and via a membrane 1,25D-binding protein [protein disulfide isomerase family A, member 3 (PDIA3)], which activates protein kinase C-signaling. The aims of this study were to determine whether these receptors are regulated during osteogenic differentiation of stem cells and if stem cells and differentiated progeny are responsive to 1,25D. mRNA and protein levels for VDR, PDIA3, and osteoblast-associated proteins were measured in undifferentiated cells and in cells treated with osteogenic medium. Mouse EBs expressed both VDR and PDIA3, but VDR increased as cells underwent osteogenic differentiation. Human MSCs expressed Pdia3 at constant levels throughout differentiation, but VDR increased in cells treated with osteogenic medium. These results suggest that both 1,25D signaling mechanisms are important, with PDIA3 playing a greater role during early events and VDR playing a greater role in later stages of differentiation. Understanding these coordinated events provide a powerful tool to control pluripotent and multipotent stem cell differentiation through induction medium.
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332-0363, USA.
Rene
R
Olivares-Navarrete
Ken
K
Sutha
Sharon L
SL
Hyzy
Daphne L
DL
Hutton
Zvi
Z
Schwartz
Todd
T
McDevitt
Barbara D
BD
Boyan
D000818:Animals; D000943:Antigens, Differentiation / Q000378:metabolism; D002117:Calcitriol / Q000502:physiology; D002454:Cell Differentiation; D058732:Embryoid Bodies / Q000378:metabolism / Q000502:physiology*; D005786:Gene Expression Regulation; D005994:Glycerophosphates / Q000502:physiology; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000378:metabolism / Q000502:physiology*; D051379:Mice; D010012:Osteogenesis; D010641:Phenotype; D019704:Protein Disulfide-Isomerases / Q000235:genetics / Q000378:metabolism; D018167:Receptors, Calcitriol / Q000235:genetics / Q000378:metabolism*
D000943:Antigens, Differentiation; D005994:Glycerophosphates; D018167:Receptors, Calcitriol; C513195:Pdia3 protein, mouse; D019704:Protein Disulfide-Isomerases; D002117:Calcitriol; C031463:beta-glycerophosphoric acid